Jul 3, 2018

Can Aspirin Reduce the Risk of Alzheimer's Disease?

A regimen of low-dose aspirin may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological researchers at Rush University Medical Center.

Alzheimer's in the brain

By Alzheimer's Reading Room

Building on previous studies demonstrating a link between aspirin and reduced risk and prevalence of Alzheimer's disease, researchers were able to show that aspirin decreases amyloid plaque pathology in the brain.

Note to readers. I put this up because I started taking one quarter of an aspirin daily about 25 years ago. You might want to consider this and the findings of this research study.

What is the Difference Between Alzheimer’s and Dementia

Can aspirin treat Alzheimer's?

Subscribe to the Alzheimer's Reading Room

"The results of the study identifies a possible new role for one of the most widely used, common, over-the-counter medications in the world," said Kalipada Pahan, Ph.D., the study's senior author and lead research investigator, who also is the Floyd A. Davis, MD, Endowed Chair of Neurology and professor of neurological sciences, biochemistry and pharmacology in Rush Medical College.
Alzheimer's disease is a fatal form of dementia that affects up to 1 in 10 Americans age 65 or older.
  • To date, the FDA has approved very few drugs for the treatment of Alzheimer's disease related dementia and the medications that exist can only provide limited symptomatic relief.
  • The exact cause of Alzheimer's disease progression is unknown; however, poor disposal of the toxic protein amyloid beta in the brain is a leading mechanism in dementia and memory loss.

Activating the cellular machinery responsible for removing waste from the brain therefore has emerged as a promising strategy for slowing Alzheimer's disease.

Amyloid beta forms clumps called amyloid plaques,

which harm connections between nerve cells and are one of the major signs of Alzheimer's disease. 

Building on previous studies demonstrating a link between aspirin and reduced risk and prevalence of Alzheimer's disease, Pahan and his colleagues were able to show that aspirin decreases amyloid plaque pathology in mice by stimulating lysosomes—the component of animal cells that help clear cellular debris.

Aspirin treats Alzheimer's

  • "Understanding how plaques are cleared is important to developing effective drugs that stop the progression of Alzheimer's disease," said Pahan.

A protein called TFEB is considered the master regulator of waste removal. The researchers gave aspirin orally for a month to genetically modified mice with Alzheimer's pathology, then evaluated the amount of amyloid plaque in the parts of the brain affected most by Alzheimer's disease.

They found that the aspirin medications augmented TFEB, stimulated lysosomes and decreased amyloid plaque pathology in the mice.

"This research study adds another potential benefit to aspirin's already established uses for pain relief and for the treatment of cardiovascular diseases," said Pahan. 

"More research needs to be completed, but the findings of our study has major potential implications for the therapeutic use of aspirin in AD and other dementia-related illnesses."

Significance statement: Developing drugs for the reduction of amyloid beta containing senile plaque, one of the pathological hallmarks of Alzheimer's disease (AD), is an important area of research.

Aspirin, one of the most widely-used medications in the world, activates peroxisome proliferator-activated receptor α (PPARα) to upregulate TFEB and increase lysosomal biogenesis in brain cells.

Accordingly, low-dose aspirin decreases cerebral plaque load in a mouse model of Alzheimer's disease via PPARα. These results delineate a new mode of action of aspirin, which may be beneficial for AD as well as lysosomal storage disorders.

Finding were published in the Journal of Neuroscience

Related Articles

Test Your Memory for Dementia in 15 Minutes (SAGE)

Problems with Balance, Walking, Falling Can Be an Early Sign of Dementia

Does the Combination of Aricept and Namenda Slow the Rate of Decline in Alzheimer's Patients

Can An Undetected Urinary Tract Infection Can Kill an Alzheimer's Patient

Learn More from Our Award Winning Knowledge Base

Caregiver Brain Alzheimer's

13 Things Every Alzheimer's Caregiver Needs to Know

How do you talk and communicate effectively with a dementia patient

You are reading original content the Alzheimer's Reading Room

The Alzheimer's Reading Room is the publisher of high quality expert content and news for the Alzheimer's and dementia community.

The Award Winning Alzheimer’s Reading Room Knowledge Base is considered to be the highest quality, deepest collection, of information on Alzheimer’s and dementia in the world.

The Knowledge Base is easy to use and easy to search. It is ideal for caregivers, educators, and dementia care professionals.

Search Our Award Winning Knowledge Base for Answers to Your Questions About Alzheimer's and Dementia

Alzheimer's Reading Room

More information:
Sujyoti Chandra et al,
Aspirin induces Lysosomal biogenesis and attenuates Amyloid plaque pathology in a mouse model of Alzheimer's disease  
The Journal of Neuroscience (2018).
DOI: 10.1523/JNEUROSCI.0054-18.2018 ,